| Pharmaceutical active ingredients: |
| Ondansetron |
| Available forms, composition and doses of Ondansetron-RL Zydis: |
| Wafer; Oral; Ondansetron 4 mgWafer; Oral; Ondansetron 8 mg |
| Ondansetron-RL Zydis medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |